Dendreon Corp fka DNDNQ

[ocyanblue]

However when Gleason score was used in a cox model by the FDA statistician he showed that the p-value was not statistically significant. By not including Gleason score in the cox model Dendreon were able to demonstarte that 9902a could be statisticaly significant.

Gleason probably had little to do with it. It was more likely that the non-stat-sig finding was because of what covariates the FDA statistician left out of the model. In turn, that included more patients in the analysis. The main issue with Dendreon's Cox analysis was that, of the patients excluded due to missing data on certain covariates, the controls lived longer than the treated.